ANIP
ANI Pharmaceuticals, Inc.
stockNASDAQ
ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 67.41 | 2026-11-06 | +5.99% | -0.893 |
| 1M | 70.84 | 2026-10-13 | +0.86% | 0.314 |
| 3M | 74.77 | 2026-08-13 | -4.44% | 0.374 |
| 6M | 80.88 | 2026-05-13 | -11.66% | 0.001 |
| 1Y | 84.55 | 2025-11-13 | -15.49% | 0.258 |
| 2Y | 59.83 | 2024-11-13 | +19.42% | — |
| 5Y | 45.56 | 2021-11-12 | +56.83% | 0.696 |
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) stock price today is $71.45, and today's volume is 383,855. ANIP is up 0.549% today. The 30 day average volume is 432,924. ANIP market cap is $1.62B with 22.73M shares outstanding.